Introduction

Most Gram-negative bacteria contain outer membrane lipopolysaccharide (LPS) that is crucial for maintaining structural integrity and protection from toxins and antibiotics13. The ATP-Binding Cassette (ABC) transporter MsbA flips an LPS-precursor, lipooligosaccharide (LOS), from the cytosolic leaflet to the periplasmic leaflet of inner membrane, a process powered by the hydrolysis of adenosine triphosphate (ATP). MsbA functions as a homodimer and each subunit consists of a soluble nucleotide-binding domain (NBD) and a transmembrane domain containing six transmembrane helices4. The proposed mechanism of MsbA-mediated LOS transportation involves the binding of LOS to the interior binding site and a conformational change from an inward-facing conformation (IF) to an outward-facing conformation (OF).

Like other ABC transporters, the ATPase activity of MsbA can be stimulated in the presence of different substrates, particularly hexaacylated lipid A species.57 Recent studies show that the locations and importance of several LOS binding sites on MsbA811. The interior binding site is located in the inner cavity, and mutations (R78A, R148A and K299A) engineered to disrupt binding at this site abolish lipid-induced ATPase activity and adversely affect cell growth.8,12 More recently, the LPS-precursor 3-deoxy-D-manno-oct-2-ulosonic (Kdo)2-lipid A (KDL) was found to bind to an exterior site on MsbA trapped in an OF conformation with adenosine 5’-diphosphate and vanadate57. Similarly, introducing mutations to disrupt binding at the exterior site also abolishes lipid-induced stimulation of ATPase activity.10

In 1984, Fersht and colleagues introduced the biochemistry community to the application of double mutant cycles as means to quantify the strength of intramolecular and intermolecular interactions.13 The method has proven to be highly effective in examining pairwise interactions, as demonstrated by its notable application in determining the spatial orientation of potassium channel residues in relation to high-affinity toxin binding.14 More generally, the technique has been used to measure the strength and coupling for residues in protein-protein complexes, protein-ligand complexes, and electrostatic interactions of residues in alpha helices.1321 In general, mutant cycles analysis involves measuring the change Gibbs free energy for some process, such as ligand binding to the wild-type protein (P), two single point mutations (PX and PY) and the double mutant protein (PXY) (for review see 15). If residue X and Y are independent of each other, then the Gibbs free energy associated with the double mutant protein will be equal to the sum of changes in Gibbs free energy due to the single mutations relative to the wild-type protein. However, if the Gibbs free energy associated with the structural and functional properties of the double mutant protein differs from the sum of single mutant proteins, then the two residues are energetically coupled. The coupling free energy (ΔΔGint) is the energy difference between double mutant and two single mutant proteins (see methods). The ΔΔGint values for pairwise interactions in proteins has revealed the contributions of salt bridges (4-20 kJ/mol), aromatic-aromatic interactions (4 kJ/mol), and charge-aromatic interactions (4 kJ/mol) to protein stability.15, 22, 23

Native mass spectrometry (MS) is well suited to characterize the interactions between protein and other molecules, especially for membrane proteins.2426 The technique is capable of maintaining non-covalent interactions and native-like structure in the gas phase,27, 28 essential for studying biochemical interactions with small molecules, such as the binding of drugs, lipids, and nucleotides.2835 In combination with a variable temperature nano electrospray ionization device, native MS has determined the thermodynamics for protein-protein and protein-ligand interactions.3641 For example, the molecular interaction between the signaling lipid 4,5-bisphosphate phosphatidylinositol and Kir3.2 is dominated by a large, favorable change in entropy.40 Recently, native MS has been combined with mutant cycles analysis to determine the energetic contribution of pairwise inter-protein interactions.42, 43 Notably, the coupling energies determined by native MS and isothermal calorimetry are in agreement.42

Recently, we reported results using native MS that reveal conformation-dependent lipid binding affinities to MsbA.10 As these measurements were performed at a single temperature, we set out to perform a more detailed thermodynamic analysis to better understand the molecular driving forces that underpin specific MsbA-lipid interactions. Here, we report binding thermodynamics (ΔH, ΔS, and ΔG) for KDL binding to MsbA in IF and OF conformations. We also carried out mutant cycles analysis to interrogate KDL binding to the exterior and interior sites on MsbA. These results reveal the unique thermodynamic contributions of MsbA residues that engage KDL. We also report coupling energetics (ΔΔGint) for pairwise interactions, including the contributions from coupling enthalpy (ΔΔHint) and coupling entropy (Δ(-TΔSint)), providing rich molecular insight specific protein-lipid interactions.

Results

MsbA residues selected for mutant cycles analyses

MsbA is known to bind LOS either in the inner cavity or at the two exterior sites (Fig. 1). For both sites, a series of conserved arginine and lysine residues form specific interactions with the headgroup of LOS. To perform mutant cycles analysis, we introduced single mutations into MsbA to target LOS binding to the interior (MsbAR78A and MsbAR299A) and exterior (MsbAR188A, MsbAR238A, and MsbAK243A) sites. More specifically, R78 coordinates one of the characteristic phosphoglucosamine (P-GlcN) substituents of LOS whereas K299 interacts with a carboxylic acid group in the headgroup of LOS. The two P-GlcN constituents of LOS are coordinated by R238 and R188 + K243, respectively. R188 also forms an additional hydrogen bond with the headgroup of LOS. In addition, we prepared double and triple mutants of MsbA for the various residues that were selected for mutagenesis.

The two distinct LPS binding sites of MsbA and their molecular interactions.

a) Two views of LPS bound to the interior site or central cavity of MsbA. The protein shown is also bound to the inhibitor G907 (PDB 6BPL).9 The protein and lipid are shown in cartoon and stick representation, respectively. b) Molecular details of the residues interacting with LPS at the interior site. Bonds are shown as dashed yellow lines along with residue labels. c) Two views of the KDL molecules bound to the two exterior binding sites of MsbA that are symmetrically related (PDB 8DMM).10 Shown as described in panel A. d) Molecular view of KDL bound to MsbA and shown as described in panel B. The asterisk denotes residues selected for mutant cycle analysis.

Thermodynamics of MsbA-KDL interactions

We performed titrations to determine the equilibrium binding affinity for MsbA-KDL interactions at four different temperatures (288, 293, 298 and 303 K) (Fig. 2). The transporter was stable at the selected temperatures. For example, binding of KDL to MsbA was enhanced at higher temperatures (Fig. 2a), indicating a favorable entropy for the interaction. For a given temperature, the mass spectra from the titration series were deconvoluted and equilibrium dissociation constants (KD) were determined for MsbA binding up to three KDL molecules (Fig. 2b, Supplementary Fig. 1 and Supplementary Table 1). Interestingly, van’ t Hoff analysis showed a non-linear trend for three KDL binding reactions (Fig. 2c), indicating that over the selected temperature range, heat capacity is not constant.44 The nonlinear form of the van’t Hoff equation enabled us to determine the ΔH and change in heat capacity (ΔCp) at a reference temperature of 2981K (Fig 2c-d). In this case, ΔG was calculated directly from KD values, and entropy (ΔS) was back calculated using both ΔH and ΔG. ΔG values for binding KDL1-2 range from -32.0 ± 0.1 to -35.2 ± 0.1 kJ/mol. The binding reaction has a positive ΔCp that alters the thermodynamic parameters at different temperatures. At the lowest temperature, KDL binding is driven by favorable enthalpy (-36 ± 12 to -43 ± 7 kJ/mol) with a small entropically penalty (-TΔS, 2 ± 11 to 12 ± 7 kJ/mol at 288 K).

Thermodynamics of KDL binding at the interior site to wild-type and mutant MsbA.

a) Representative deconvoluted native mass spectra of 0.39 μM wild-type MsbA solubilized in the C10E5 detergent and in the presence of 0.6 μM KDL recorded at different solution temperatures. b) Plot of mole fraction of MsbA (KDL)0-3 determined from titration of KDL (dots) at 298 K and resulting fit from a sequential ligand binding model (solid line, R2 = 0.99). c) van’ t Hoff plot for MsbA(KDL)1-3 and resulting fit of a nonlinear van’ t Hoff equation. d) Thermodynamics for MsbA and mutants (MsbAR78A, MsbAK299A and MsbAR78A,K299A) binding KDL at 298 K. e) Mutant cycles for MsbA and mutants with (from left to right) ΔΔG (mutant minus wild-type), ΔΔH and Δ(-TΔS) values indicated over the respective arrows. Shown are values at 298K. Reported are the average and standard deviation from repeated measurements (n:=:3).

In contrast, KDL binding at higher temperatures displays a large, favorable entropy (-TΔS, -123 ± 12 to -146 ± 7 kJ/mol at 303 K) that compensates a large enthalpic barrier (86 ± 12 to 112 ± 7 kJ/mol). These results highlight the role of entropy in LOS binding to MsbA that may stem from solvent reorganization.

KDL binding to the interior binding site of MsbA

We next determined the thermodynamics of KDL binding to MsbA containing single and double mutations at the interior binding site (Fig 2d). MsbAR78A showed a reduction in binding KDL with ΔG ranging from -30.2 ± 0.2 to -32.5 ± 0.2 kJ/mol. At 298K, KDL binding is enthalpically and entropically favorable whereas binding of the second KDL is similar to the wild-type protein (Fig. 2d). The binding thermodynamics for MsbAK299A is reminiscent of the wild-type protein with a large, favorable change in entropy (-TΔS, -75 ± 2 to -86 ± 1 kJ/mol at 298 K) and unfavorable enthalpy (43 ± 2 to 53 ± 1 kJ/mol) (Fig. 2d). The double mutant MsbAR78A,K299A protein shows a reduction in opposing entropic and enthalpic terms leading to an increase in ΔG by ∼4 kJ/mol (Fig. 2d). Mutant cycle analysis indicates a coupling energy (ΔΔGint) of 1.7 ± 0.4 kJ/mol that contributes to the stability of KDL-MsbA complex (Fig. 2e and Supplementary Table 3). Interestingly, the coupling enthalpy (ΔΔHint of -26 ± 15 kJ/mol) and coupling entropy (Δ(-TΔS)int of 28 ± 15 kJ/mol at 298K) indicating that these residues contribute to KDL binding through an entropy driven process that overcomes an enthalpic barrier(Fig. 2e and Supplementary Table 3).

KDL binding to the exterior binding site of MsbA

The recently discovered exterior KDL binding site10 located on the cytosolic leaflet of inner membrane has not been thoroughly investigated, prompting us to characterize this site by a triple mutant cycle (Fig 3). We first investigated R188 and K243, residues that both interact with one of the P-GlcN moieties of LOS. Both MsbAR188A and MsbAK243Asingle mutants marginally weakened the interaction by about 2 kJ/mol (Fig 3a). Enthalpy and entropy for KDL binding MsbAR188A was largely similar to the wild-type protein (Fig 3a). However, the R243A mutation resulted in an increase in entropy, compensated for by an increase in positive enthalpy (Fig 3a). ΔG for MsbAR188A,K243A was comparable to the K243A single mutant form of the protein (Fig 3a). The positive coupling energy of 3.2 ± 0.4 kJ/mol with contributions from a coupling enthalpy of 19 ± 11 kJ/mol and a coupling entropy of -16 ± 12 kJ/mol at 298K (Fig 3b and Supplementary Table 3). MsbA containing the R238A mutation significantly weakened the interaction with KDL, increasing ΔG by nearly 5 kJ/mol (Fig 3b and Supplementary Table 3). Combining this mutation with R188A, decreased ΔH by 57 kJ/mol at the cost of increasing-TΔS by 64 kJ/mol at 298K (Fig 3b and Supplementary Table 3). The coupling energy for R188A and R238A is approximately zero as a result of equal coupling enthalpy and entropy of different signs. Compared to the wild-type protein, MsbAR238A,K243A results in an inversion of the thermodynamic signature with binding now being driven by enthalpy. More specifically, this inversion is accompanied by ΔΔH and Δ(-TΔS) of -93 ± 7 kJ/mol and 99 ± 7 kJ/mol at 298K (Fig 3b and Supplementary Table 3). Again, the coupling enthalpy and entropy (at 298K) of equal magnitude but opposite signs give rise to a coupling energy of zero for R238A and R243A (Fig 3b and Supplementary Table 3). Introduction of the R188A mutation into MsbAR238A,K243A, results in reversal of the thermodynamic signature to mirror that of MsbAR188A,K243A (Fig 3a). The coupling energy, coupling enthalpy, and coupling entropy for R188A, R238A and R243A are 3.4 ± 0.5 kJ/mol, 100 ± 16 kJ/mol, and -97 ± 16 kJ/mol at 298K (Supplementary Table 4), respectively. Taken together, these results demonstrate KDL binding to MsbA is sensitive to mutations at both the interior and exterior sites.

Triple mutant cycle analysis of the exterior LPS binding site of MsbA.

a) Thermodynamics for MsbA and mutants (MsbAR188A, MsbAR238A, MsbAK243A, MsbAR188A,R243A, MsbAR188A,K243A, MsbAR238A,R243A, and MsbAR188A,R238A,K299A) binding KDL at 298 K. b) Triple mutant cycles for MsbA and mutants with (from left to right) ΔΔG, ΔΔH and Δ(-TΔS) values indicated over the respective arrows. Shown are values at 298K. Reported are the average and standard deviation from repeated measurements (n⍰=⍰3).

Dissecting KDL binding to the interior and exterior site(s) of MsbA

An open question is if the interior and exterior LOS binding sites of MsbA are allosterically coupled? We focused on the R188A and K299A mutants located at the exterior and interior binding sites, respectively. Results for both single mutants were presented above. MsbA containing the R188A and K299A mutations drastically reduced the binding of KDL (Fig 4a). The ΔG for MsbAR188A,K299A increased by more than 6 kJ/mol compared to the wild-type protein (Fig 4b). This approximately doubles compared to MsbA containing either of the single point mutations. Mutant cycle analysis revealed a negative coupling energy of -1.1 ± 0.4 kJ/mol that partitioned into a coupling enthalpy of -36 ± 13 kJ/mol and coupling entropy of 34 ± 13 kJ/mol at 298K (Fig. 4b and Supplementary Table 3). In short, mutations at either LOS binding site have a negative impact on binding that is accompanied by a gain in both favorable entropy and unfavorable enthalpy.

Mutant cycle of MsbA residues located within the interior and exterior LOS bind sites.

a) Representative deconvoluted native mass spectra of 0.39 μM MsbA and mutants in the presence of 0.8 μM KDL. b) Thermodynamic signatures for MsbA and mutants binding KDL at 298 K. c) Double mutant cycle analysis for R188 and K299. Shown from left to right is ΔΔG, ΔΔH and Δ(-TΔS) and the values indicated over the respective arrows at 298K. Reported are the average and standard deviation from repeated measurements (n⍰=⍰3).

Mutant cycle analysis of KDL binding to vanadate-trapped MsbA

The structure of KDL bound to MsbA was determined with the transporter trapped in an open, OF conformation with ADP and vanadate.10 After trapping the transporter in a similar fashion, we characterized the binding of KDL to MsbA and proteins containing single R188A, R238A, and K243A mutations. Here, we focused on the binding of the first and second lipid, since MsbA has two, symmetrically related KDL binding sites in the open, OF conformation. Thermodynamics of MsbA(KDL)1-2 binding is like the non-trapped transporter, wherein entropy (-TΔS ranging from -58 ± 1 to -69 ± 1 kJ/mol at 298K) is more favorable than a positive enthalpic term (ΔH ranging from 22 ± 1 to 35 ± 1 kJ/mol) (Fig. 5a). The single mutant proteins (MsbAR188A, MsbAR238A, and MsbAK243A) showed a slight increase in ΔG (at most 5 kJ/mol) (Fig. 5a). Notably, we found MsbAR238A and MsbAK243A had about a four-fold increase in ΔH and favorable entropy was about two-fold higher (Fig. 5a). Double mutant cycle analysis of the pairwise mutants revealed a positive coupling energy of ∼2 kJ/mol for MsbA binding one and two KDLs (Fig. 5b and Supplementary Table 7). Focusing on the first KDL binding event, the coupling enthalpy and coupling entropy at 298K for R188 and K238 was 89 ± 7 kJ/mol and -87 ± 7 kJ/mol, respectively (Fig. 5b and Supplementary Table 7). Likewise, R238 and K243 showed 129 ± 11 kJ/mol of coupling enthalpy and -127 ± 11 kJ/mol of coupling entropy at 298K (Fig. 5b and Supplementary Table 7). However, the R188 and K243 pair revealed a relatively low coupling enthalpy and coupling entropy at 298K of 3.5 ± 7 kJ/mol and 2 ± 7 kJ/mol, respectively (Fig. 5b and Supplementary Table 7). These results highlight the importance of entropic and enthalpic contributions that underpin specific lipid binding sites.

Double mutant cycles reveal thermodynamic insight into KDL binding at the exterior site of MsbA.

a) Thermodynamic signatures for MsbA and mutants binding KDL at 298 K. c-d) Double mutant cycle analysis for pairs of R188, R238, and K243 with a total of three combinations. Shown are results for the first (panel c) and second (panel d) KDL binding to MsbA trapped in an open, OF conformation with ADP and vanadate. Within each panel, ΔΔG, ΔΔH and Δ(-TΔS) are shown from left to right and their values at 298K indicated over the respective arrows. Reported are the average and standard deviation from repeated measurements (n⍰=⍰3).

Discussion

Thermodynamics provide unique insight into the molecular forces that drive specific MsbA-KDL interactions. A recurring thermodynamic strategy for specific KDL-MsbA interactions is a large, favorable entropic term that opposes a positive enthalpic value. The human G-protein-gated inward rectifier potassium channel (Kir3.2) also used a similar thermodynamic strategy to engage phosphoinositides (PIPs).40 The large, positive entropy could stem from solvent reorganization of lipid headgroup containing carbohydrate groups, and desolvation of hydrated binding pockets on the membrane protein. The release of these ordered water molecules to bulk solvent contributes favorably to entropy. These experiments are performed in detergent and reorganization of detergent may also play a role. Previous work has shown soluble protein-ligand interactions can be driven by a large, positive entropy term that outweighs a large, positive enthalpic penalty.4548 In these cases, the reaction is mainly driven by conformational entropy originating in enhanced protein motions. However, it is unclear if the conformational dynamics of MsbA are enhanced when bound to KDL.

Most of the van’ t Hoff plots followed non-linear trends. This results indicate that Cp is not constant over the selected temperature range.44 In nearly all cases, a positive ΔC was observed that ranged from 4 to 12 kJ/mol·K (Supplementary Table 2, 6). Solvation of polar groups in aqueous solvent has been ascribed to positive heat capacities whereas negative for apolar solvation.44, 49 Reorganization of the hydrated, polar headgroups of KD is consistent with the positive heat capacity observed here. However, change in heat capacity could also be ascribed to temperature-dependent conformational changes in MsbA and/or KDL. Notably, vanadate-trapped MsbA locked in an open, OF conformation should be less conformationally dynamic than the apo protein, which is known to adopt a number of open, IF conformations where the NBDs are separated at different distances. Similar positive heat capacities were observed for the different conformations, suggesting the dynamics of MsbA marginally contribute to the observed non-linear trends. Notably, the headgroup of KDL is nestled in a hydrophilic, basic patch of MsbA in the open, OF conformation. Similarly, the headgroup of PIP binds a hydrophilic, basic pocket in Kir3.2. These hydrophilic patches will be highly solvated, which will be desolvated upon binding lipids contributing to entropy. In the case of MsbA, the selected lysine and arginine residues separation (based alpha carbon position) that ranges about 9 to 18 Å (PDB 8DMM). This distance could result in overlap of solvation shells that collectively contribute to the positive coupling enthalpy observed for MsbA-KDL interactions.

Thermodynamics of MsbA-lipid interactions contrast those observed for a different membrane protein. Phospholipid binding to the bacterial ammonia channel (AmtB) were largely driven by enthalpy and, in most cases, entropy was unfavorable.50 Another interesting observation for AmtB-lipid interactions was significant enthalpy-entropy compensation for each sequential lipid binding event. Here, enthalpy-entropy compensation is not as pronounced. This result may reflect the much higher-affinity and specific MsbA-KDL interactions compared to the weaker AmtB-lipid interactions.

Results of this study begin to draw a connection between LOS binding at the interior and exterior sites of MsbA. It is presently thought that flipping of LOS occurs at interior MsbA site, and the exterior LOS binding site enables feedforward activation, wherein binding of LOS and precursors thereof stimulates ATPase activity.810, 5154 It is also thought that binding of LOS and ATP promotes dimerization of the NBDs. Here, we find mutations at either the interior or exterior sites have a direct impact of KDL binding MsbA, which under these conditions is presumably adopting an open, IF conformation. Of the mutant proteins, MsbA containing single mutations (MsbAR188A,K299A) at both LOS binding sites resulted in the greatest change in ΔG. This result implies that these sites are allosterically coupled and further investigation is warranted to better understand how the exterior LOS binding sites influence MsbA dynamics.

A defining feature of this work is the use of mutant cycles to not only characterize specific membrane protein-lipid interactions but define the coupling energies of pairwise interactions in terms of enthalpic and entropic contributions. Traditionally, mutant cycles have been used to understand pairwise interactions of residues, such as in protein-protein complexes. Here, we extend mutant cycles to understand how pairs of residues contribute to specific MsbA-KDL interactions. Double mutants targeting the interior site reveal a positive coupling energy of nearly 2 kJ/mol for R78 and K299. These stabilize the MsbA-KDL complex largely through nearly 17 kJ/mol of favorable coupling entropy, which outweighs a negative coupling enthalpy. This phenomenon extends to nearly all mutant cycles investigated in this work, even when the transporter is trapped with vanadate. The largest coupling energy is observed from the triple mutant cycle of R188A, R238A and R243A, which again stabilization of the complex was achieved via favorable coupling entropy. While we focused on results at 298K, the coupling energetics among these three residues show 3.4 ± 0.5 kJ/mol. Taken together, mutant cycle analysis reveals that entropy drives high-affinity KDL binding to MsbA where solvent reorganization plays a central role (Figure 6).

The role of solvent in the molecular recognition of membrane protein-lipid complexes.

The lipid headgroup and binding pocket (basic patch illustrated in blue) on the membrane protein are solvated. The ordered solvent (shown in light blue) is then displaced upon lipid binding the membrane protein leading to solvent reorganization. The displacement of ordered solvent (show in light green) contributes to favorable entropy. This process enables the formation of a high affinity, stable membrane protein-lipid complex.

In summary, we demonstrate the utility of native MS to determine the thermodynamic origins of specific KDL-MsbA interactions. Combined with the classical mutant cycle approach,13 the thermodynamic contribution of specific interactions with lipids is illuminated. More specifically, MsbA binding KDL is solely driven by entropy, which overcomes an enthalpic penalty. This thermodynamic strategy was also observed for Kir3.2-PIP interactions. It is tempting to speculate that favorable entropy is a common theme enabling membrane proteins to specifically engage carbohydrate containing lipids. We envision thermodynamics and mutant cycles will be invaluable in not only better understanding high-affinity lipid binding sites but also in the development of inhibitors, such as those that may target specific protein-lipid binding site(s). In closing, these studies provide deeper insight into the thermodynamic strategies membrane proteins adopt to achieve high-affinity lipid binding site(s).

Methods

MsbA expression constructs

MsbA and mutants were essentially expressed and purified as previously described.10 In detail, the MsbA gene (from Escherichia coli genomic DNA) was amplified by polymerase chain reaction (PCR) using Q5 High-Fidelity DNA Polymerase (New England Biolabs, NEB) and subcloned into a modified pCDF-1b plasmid (Novagen) resulting in expression of MsbA with an N-terminal TEV protease cleavable His6 fusion protein. Primers for generating mutations for MsbA were designed using the online tool NEBaseChanger (NEB) and carried out using the KLD enzyme mix (NEB) as described by the manufacturer. All plasmids were confirmed by DNA sequencing.

Protein expression and purification

MsbA expression plasmids were transformed into E. coli (DE3) BL21-AI competent cells (Invitrogen). A single colony was picked and used to inoculate 50 mL LB media to be grown overnight at 37 °C with shaking. The overnight culture was used to inoculate to terrific broth (TB) media and incubated at 37 °C until the OD600nm ≈ 0.6-1.0. After which, the cultures were induced with final concentration of 0.5 mM IPTG (isopropyl β-D-1-thiogalactopryanoside) and 0.2% (w/v) arabinose. After overnight expression at 25 °C, the cultures were harvested at 4000 x g for 10 minutes and the resulting pellet was resuspended in lysis buffer (20 mM Tris, 300 mM NaCl and pH at 7.4 at room temperature). The resuspended cells were centrifuged, and the pellet was then resuspended in lysis buffer. Cells were lysed by four passages through a Microfluidics M-110P microfluidizer operating at 25,000 psi with reaction chamber emersed in an ice bath. The lysate was clarified by centrifugation at 20,000 x g for 25 minutes and the supernatant was centrifuged at 100,000 x g for 2 hours to pellet membranes. Resuspension buffer (20 mM Tris, 150 mM NaCl, 20% (v/v) glycerol, pH 7.4) was used to homogenize the resulting pellet and 1% (m/v) DDM was added for protein extraction overnight at 4 °C. The extraction was centrifuged at 20,000 x g for 25 minutes and the resulting supernatant was supplemented with 10 mM imidazole and filtered with a 0.45 µm syringe filter prior to purification by immobilized metal affinity chromatography. The extraction containing solubilized MsbA was loaded onto a column packed with 2.5 mL Ni-NTA resin pre-equilibrated in NHA-DDM buffer (20 mM Tris, 150 mM NaCl, 10 mM imidazole, 10% (v/v) glycerol, pH 7.4 and supplemented with 2x the critical micelle concentration (CMC) of DDM). After the loading, the column was washed with 5 column volumes (CV) of NHA-DDM buffer, 10 CV of NHA-DDM buffer supplemented with additional 2% (w/v) nonyl-ß-glucoside (NG), and 5 CV of NHA-DDM buffer. The immobilized protein was eluted with the addition of 2 CV of NHB-DDM buffer (20 mM Tris, 150 mM NaCl, 250 mM imidazole, 10% (v/v) glycerol, 2 x CMC of DDM, pH 7.4). The eluted MsbA was pooled and desalted using HiPrep 26/10 desalting column (GE Healthcare) pre-equilibrated in desalting buffer (NHA-DDM with imidazole omitted). TEV protease (expressed and purified in-house) was added to the desalted MsbA sample and incubated overnight at room temperature. The sample was passed over a pre-equilibrated Ni-NTA column and the flow-through containing the cleaved MsbA protein was collected. The pooled protein was concentrated using a centrifugal concentrator (Millipore, 100 kDa) prior to injection onto a Superdex 200 Increase 10/300 GL (GE Healthcare) column equilibrated with 20 mM Tris, 150 mM NaCl, 10% (v/v) glycerol and 2x CMC C10E5. Peak fractions containing dimeric MsbA were pooled, flash frozen in liquid nitrogen, and stored at -80 °C prior to use.

Preparation of MsbA for native MS studies

MsbA samples were incubated with 20 µM copper (II) acetate, to saturate the N-terminal metal binding site,10 prior to buffer exchange using a centrifugal buffere exchange device (Bio-Spin, Bio-Rad) into 200 mM ammonium acetate supplemented with 2 x CMC of C10E5. To prepare vanadate-trapped MsbA, ATP and MgCl2 were added to MsbA at a final concentration of 10mM. After incubation at room temperature for 10 minutes, a freshly boiled vanadate solution (pH 10) was added to reach final concentration of 1 uM followed by incubation at 37 °C for an additional 10 minutes. The sample was then buffer exchanged as described above.

Native Mass Spectrometry

Samples were loaded into gold-coated glass capillaries made in-house55 and introduced into at a Thermo Scientific Exactive Plus Orbitrap with Extended Mass Range (EMR) using native electrospray ionization source modified with a variable temperature apparatus.41 For native mass analysis, the instrument was tuned as follow: source DC offset of 10 V, injection flatapole DC to 8.0 V, inter flatapole lens to 4, bent flatapole DC to 3, transfer multipole DC to 3 and C trap entrance lens to 0, trapping gas pressure to 6.0 with the in-source CID to 65.0 eV and CE to 100, spray voltage to 1.70 kV, capillary temperature to 200 °C, maximum inject time to 200 ms. Mass spectra were acquired with a setting of 17,500 resolution, microscans set to 1 and averaging set to 100.

Determination MsbA-lipid equilibrium binding constants

KDL (Avanti) stock solution was prepared by dissolving lipid powder in water. The concentration of MsbA and KDL were determined by a DC protein assay (BioRad) and phosphorus assay, respectively.56, 57 MsbA was incubated with varying concentrations of KDL before loading into a glass emitter and mounted on a variable-temperature electrospray ionization (vT-ESI) source.41 Samples were incubated in the source for two minutes at the desired temperature before data acquisition. All titration data were collected in triplicate. At a given temperature, the mass spectra were deconvoluted using Unidec58 and the peak intensities for apo and KDL-bound species were determined and converted to mole fraction. The sequential ligand binding model was applied to determine the mole fraction of each species in measurement:

Where:

To calculate the mole fraction of a particular species:50

For each titrant in the titration, the free concentration of lipid was computed as follows:

The sequential ligand binding model was globally fit to the mole fraction data by minimization of pseudo-χ2 function:

where n is the number of bound ligands and d is the number of the experimental mole fraction data points.

Van’t Hoff analysis59 was applied to determine the Gibbs free energy change (ΔG), enthalpy change (ΔH) and entropy change (ΔS) based on the equation:

For non-linear trends, the non-linear form of the Van’t Hoff equation was applied to determine the thermodynamic parameters:60

where KA is the equilibrium association constant, K0 is the equilibrium association constant at the reference temperature (T0), ΔHTO is the standard enthalpy at T0, ΔCp is the change in heat capacity at constant pressure, and R is the universal gas constant.

Mutant cycle analysis

If the two mutated residues are interacting, then the coupling free energy (ΔΔGint) will not be 0 and the value may be positive or negative depending upon whether the interactions between mutated residues enhance or weaken the functional property measured.61 ΔΔGint can be computed given the change in Gibbs free energy for the wild-type protein (P), two single mutants (PX and PY), and double mutant (PXY) as follows:

where .

Analogously, the contributions from coupling enthalpy (ΔΔHint) and coupling entropy (Δ(-TΔSint)) can be computed as follows:

where T is temperature in K. As an example, .

Acknowledgements

This work was supported by National Institutes of Health (NIH) under grant numbers (DP2GM123486, R01GM121751, R01GM139876, R01GM138863 and RM1GM145416 to A.L.; and P41GM128577 to D.R.).

Author Contributions

J.L. and A.L. designed the research. J.L., and T.Z. expressed and purified MsbA. J.L. performed mass spectrometry experiments. J.L. and T.Z. carried out the functional assays. J.L., T.Z., M.M., D.C., D.R., and A.L. analyzed the data. J.L. and A.L. wrote the manuscript with input from the other authors.

Competing interests

The authors declare no competing interests.

Materials & Correspondence

Correspondence and requests for materials should be addressed to AL (ALaganowsky@chem.tamu.edu).